Martin Edelman, MD, Talks About Improving Outcomes in the Management of NSCLC
Martin Edelman, MD, Greenbaum Cancer Center, Baltimore, MD, says that organizations like NCCN and ASCO have guidelines for the management of non-small cell lung cancer (NSCLC). "I think that by utilizing these various clinical as well as biological markers, we can develop therapies that are tailored to the individual patient and have substantial evidence to support their use," said Dr Edelman.
This video was taken on May 2, 2013, at the NAMCP Spring Managed Care Forum in Orlando, FL.
Nina Pham was the first nurse at Texas Presbyterian Hospital in Dallas to contract the Ebola virus after caring for patient Thomas Eric Duncan, who died October 8, 2014. In an interview with The Dallas Morning News, Pham said she will sue the hospital’s parent company today for unspecified damages, citing inadequate training and safety measures and for violations to her privacy.
The Thyroid Cancer Clinical Registry is expected to improve quality of patient care as patient data would be readily available to all physicians involved in the patients care; however former Commission on Cancer chair Frederick L Greene, MD, wonders whether physicians would take the time to enter the clinical data into the system as required.
Modeling data discussed at a press conference at the 2015 Conference on Retroviruses and Opportunistic Infections showed that delaying HCV treatment, consequent to the high cost of the newer antiviral regimens, could prove fatal in patients coninfected with HIV.
A simple urine test could help to guide clinicians in the treatment of bladder cancer patients, researchers believe. Being able to reliably identify those patients with the most aggressive cancers early via urine tests, and expediting aggressive therapeutic strategies, may significantly improve outcomes, they say.